Association between Inhaled Corticosteroid Use and SARS-CoV-2 Infection: A Nationwide Population-Based Study in South Korea
Sang Chul Lee, Kang Ju Son, Chang Hoon Han, Ji Ye Jung, Seon Cheol Park
Tuberc Respir Dis. 2022;85(1):80-88.   Published online 2021 Nov 30     DOI:
Citations to this article as recorded by Crossref logo
The association between inhaled corticosteroid and the risks of SARS-COV-2 infection: A systematic review and meta-analysis
Chao-Hsien Chen, Ching-Yi Chen, Chih-Cheng Lai, Ya-Hui Wang, Kuang-Hung Chen, Cheng-Yi Wang, Yu-Feng Wei, Pin-Kuei Fu
Journal of Infection and Public Health.2023; 16(5): 823.     CrossRef
Inhaled Corticosteroids Is Not Associated with the Risk of Pneumonia in Asthma
Ye Jin Lee, Yong-Bum Park
Tuberculosis and Respiratory Diseases.2023; 86(3): 151.     CrossRef
Local budesonide therapy in the management of persistent hyposmia in suspected non-severe COVID-19 patients: Results of a randomized controlled trial
Charlotte Hautefort, Alain Corré, Guillaume Poillon, Clément Jourdaine, Juliette Housset, Michael Eliezer, Benjamin Verillaud, Dorsaf Slama, Denis Ayache, Philippe Herman, Amélie Yavchitz, Jessica Guillaume, Camille Hervé, Wissame El Bakkouri, Dominique S
International Journal of Infectious Diseases.2023; 136: 70.     CrossRef
Inhaled ciclesonide does not affect production of antibodies or elimination of virus in patients with COVID-19: Subanalysis of a multicenter, open-label randomized trial
Manabu Suzuki, Akihiro Matsunaga, Tohru Miyoshi-Akiyama, Junko Terada-Hirashima, Kenji Sadamasu, Mami Nagashima, Jin Takasaki, Shinyu Izumi, Masayuki Hojo, Yukihito Ishizaka, Haruhito Sugiyama
Drug Discoveries & Therapeutics.2023; 17(5): 304.     CrossRef
The Use of Inhaled Glucocorticosteroids (ICS) during the COVID-19 Pandemic
A. A. Vizel, I. Yu. Vizel, M. K. Sagdieva, F. F. Yarkaeva
Tuberculosis and Lung Diseases.2022; 100(1): 7.     CrossRef